Silke Raffegerst

685 total citations
19 papers, 541 citations indexed

About

Silke Raffegerst is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Silke Raffegerst has authored 19 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Silke Raffegerst's work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (6 papers). Silke Raffegerst is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (6 papers). Silke Raffegerst collaborates with scholars based in Germany, Norway and Russia. Silke Raffegerst's co-authors include Dolores J. Schendel, Marie Roskrow, Hans‐Jochem Kolb, Dmitrij Frishman, Stefani Spranger, Xiaohong Chen, Zhen Su, Michael Grau, Bernd Dörken and Kamyar Hadian and has published in prestigious journals such as Blood, Bioinformatics and PLoS ONE.

In The Last Decade

Silke Raffegerst

18 papers receiving 535 citations

Peers

Countries citing papers authored by Silke Raffegerst

Since Specialization

Citations

This map shows the geographic impact of Silke Raffegerst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Raffegerst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Raffegerst more than expected).

Fields of papers citing papers by Silke Raffegerst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Raffegerst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Raffegerst. The network helps show where Silke Raffegerst may publish in the future.

Co-authorship network of co-authors of Silke Raffegerst

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Raffegerst. A scholar is included among the top collaborators of Silke Raffegerst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Raffegerst. Silke Raffegerst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms 2025 ·Cancers* ·Simone Thomas, Martin Wermke, Vladan Vučinić, Eva Wagner-Drouet, (unknown), Robert Zeiser, Gesine Bug, Michael Schmitt, Wolfgang Herr, Petra U. Prinz, Maja Bürdek, Silke Raffegerst, Agostino Tafuri, (unknown), (unknown), (unknown), Kai Pinkernell, Dolores J. Schendel	0
2	A WT-1 and PRAME "Fast-DC" Immunotherapy As a Potential Post-Remission Strategy for AML 2020 ·Blood ·Yngvar Fløisand, Iris Bigalke, Dag Josefsen, Silke Raffegerst, (unknown), Richard Addo, Dolores J. Schendel, Kai Pinkernell, Gunnar Kvalheim	1
3	Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors 2019 ·Frontiers in Genetics ·(unknown), Silke Raffegerst, (unknown), Dolores J. Schendel, Dmitrij Frishman	31
4	DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment 2019 ·Blood ·(unknown), Silke Raffegerst, (unknown), (unknown), (unknown), Yngvar Fløisand, Dag Josefsen, Iris Bigalke, Kai Pinkernell, Gunnar Kvalheim, Dolores J. Schendel, Agostino Tafuri	5
5	Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues 2017 ·BMC Cancer ·Victor Jaravine, (unknown), Silke Raffegerst, Dolores J. Schendel, Dmitrij Frishman	21
6	Assessment of cancer and virus antigens for cross-reactivity in human tissues 2016 ·Bioinformatics ·Victor Jaravine, Silke Raffegerst, Dolores J. Schendel, Dmitrij Frishman	12
7	Prevention of Tumor Formation by Latent Gammaherpesvirus Infection 2015 ·PLoS ONE ·Silke Raffegerst, (unknown), (unknown), Heiko Adler	6
8	Expitope: a web server for epitope expression 2015 ·Bioinformatics ·Kerstin Haase, Silke Raffegerst, Dolores J. Schendel, Dmitrij Frishman	15
9	Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo 2013 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Silke Raffegerst, Susanne Wilde, Barbara Mosetter, Dolores J. Schendel, Slavoljub Milosevic	1
10	Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL 2012 ·Cancer Cell ·Daniel Nagel, Stefani Spranger, Michelle Vincendeau, Michael Grau, Silke Raffegerst, (unknown), (unknown), Martin Neuenschwander, Jens Peter von Kries, Kamyar Hadian, Bernd Dörken, Peter Lenz, Georg Lenz, Dolores J. Schendel, Daniel Krappmann	186
11	The CD6 Scavenger Receptor Is Differentially Expressed on a CD56<sup>dim</sup> Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion 2010 ·Journal of Innate Immunity ·Monika Braun, (unknown), (unknown), Silke Raffegerst, (unknown), Susanne Wilde, Stefani Spranger, Joachim W. Ellwart, Barbara Mosetter, Ludmila Umansky, (unknown), Dolores J. Schendel, Christine S. Falk	44
12	Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice 2009 ·PLoS ONE ·Silke Raffegerst, (unknown), (unknown), Josef Mysliwietz, Leticia Quintanilla-Martı́nez, Dolores J. Schendel	6
13	Antigen Presenting Cells Transfected with LMP2a RNA Induce CD4 + LMP2a-specific Cytotoxic T Lymphocytes which Kill via a Fas-independent Mechanism 2002 ·Leukemia & lymphoma ·Zhen Su, Mario Peluso, Silke Raffegerst, Dolores J. Schendel, Marie Roskrow	6
14	The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease 2001 ·European Journal of Immunology ·Zhen Su, Mario Peluso, Silke Raffegerst, Dolores J. Schendel, Marie Roskrow	53
15	Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant 2001 ·Bone Marrow Transplantation ·(unknown), Silke Raffegerst, Xian Chen, Dolores J. Schendel, HJ Kolb, Marie Roskrow	39
16	Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia 2000 ·British Journal of Haematology ·Xiaohong Chen, (unknown), Silke Raffegerst, Hans‐Jochem Kolb, Marie Roskrow	42
17	Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis 2000 ·British Journal of Haematology ·Xiaohong Chen, (unknown), Silke Raffegerst, Dolores Schendel, Hans‐Jochem Kolb, Marie Roskrow	17
18	Impaired expression of the CD3‐zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis 2000 ·British Journal of Haematology ·Xiao Chen, (unknown), Silke Raffegerst, Dolores Schendel, Hans‐Jochem Kolb, Marie Roskrow	48
19	Interferon alpha in combination with GM‐CSF induces the differentiation of leukaemic antigen‐presenting cells that have the capacity to stimulate a specific anti‐leukaemic cytotoxic T‐cell response from patients with chronic myeloid leukaemia 2000 ·British Journal of Haematology ·Xiaohong Chen, (unknown), Silke Raffegerst, Hans‐Jochem Kolb, Marie Roskrow	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact